StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock.
Retractable Technologies Trading Down 1.7 %
Shares of NYSE RVP opened at $1.14 on Wednesday. The company has a market cap of $34.13 million, a price-to-earnings ratio of -4.38 and a beta of 2.07. The stock’s 50 day simple moving average is $1.06 and its 200 day simple moving average is $1.14. Retractable Technologies has a 12-month low of $0.87 and a 12-month high of $1.34. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01.
Retractable Technologies (NYSE:RVP – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. The business had revenue of $7.60 million during the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%.
Insider Transactions at Retractable Technologies
About Retractable Technologies
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Read More
- Five stocks we like better than Retractable Technologies
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MarketBeat Week in Review – 6/10 – 6/14
- How Can Investors Benefit From After-Hours Trading
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.